Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed May 8, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-05-05$2.88/sh+5,000$14,375→ 1,337,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-05-08$2.62/sh+5,000$13,108→ 1,342,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-05-04$2.79/sh+15,000$41,882→ 1,332,700 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.85, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.9, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.575 to $2.68, inclusive.
- [F5]These shares are directly owned by Mr. Golestaneh in his personal capacity.